Histogen to Explore Strategic Alternatives
HSTO Stock | USD 0.02 0.00 0.00% |
About 61% of Histogen's investor base is looking to short. The analysis of the overall investor sentiment regarding Histogen suggests that many traders are alarmed. Histogen's investing sentiment overview a quick insight into current market opportunities from investing in Histogen. Many technical investors use Histogen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Histogen |
SAN DIEGO, July 05, 2023 Histogen Inc. , a clinical-stage therapeutics company focused on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the bodys natural process to restore immune function, today announced that it has completed a review of its business, including the status of programs, resources and capabilities, and has decided to pause further development of its programs
Read at finance.yahoo.com
Histogen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Histogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Histogen Fundamental Analysis
We analyze Histogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Histogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Histogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Histogen is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Histogen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Histogen stock to make a market-neutral strategy. Peer analysis of Histogen could also be used in its relative valuation, which is a method of valuing Histogen by comparing valuation metrics with similar companies.
Peers
Histogen Related Equities
DRUG | Bright Minds | 12.30 | ||||
CYTO | Altamira Therapeutics | 7.50 | ||||
ALRN | Aileron Therapeutics | 4.38 | ||||
CING | Cingulate | 3.81 | ||||
ARTL | Artelo Biosciences | 1.94 | ||||
PALI | Palisade Bio | 1.65 | ||||
SNTI | Senti Biosciences | 0.93 | ||||
TNXP | Tonix Pharmaceuticals | 0.00 | ||||
TPST | Tempest Therapeutics | 1.04 | ||||
CRIS | Curis | 1.35 | ||||
SONN | Sonnet Biotherapeutics | 2.28 | ||||
ENTX | Entera Bio | 3.53 | ||||
VRAX | Virax Biolabs | 4.83 |
Check out Histogen Hype Analysis, Histogen Correlation and Histogen Performance. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.81) | Revenue Per Share 0.004 | Return On Assets (0.54) | Return On Equity (1.20) |
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.